Intracavitary 5-fluoro-uracil (5-FU) in combination with systemic chemotherapy.
In 23 patients with peritoneal, pleural oder pericardial metastases the efficacy of intracavitary tumor therapy was investigated. 5-FU was administered intracavitary in all patients combined with systemic chemotherapy. 8 partial responses (34%) were achieved.
Morere
J F
JF
Department of Oncology, Avicenne Hopital, Bobigny, France.
Delanian
S
S
Boaziz
C
C
Breau
J L
JL
Israel
L
L
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002408:Catheters, Indwelling; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D007263:Infusions, Parenteral / Q000295:instrumentation; D008297:Male; D008479:Mediastinal Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008875:Middle Aged; D010496:Pericardium / Q000187:drug effects; D010534:Peritoneal Neoplasms / Q000188:drug therapy / Q000556:secondary*; D010997:Pleural Neoplasms / Q000188:drug therapy / Q000556:secondary*
D005472:Fluorouracil